Audiologists in Scarborough, ME Accepting Medicare
7 Audiologists found. Showing 1 - 7
 Mindy Hittle, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 23 Spring St, Scarborough, ME 04074 Phone: 207-883-6466 |
 Mr. Matthew Lewandowski, AUD Audiologist Medicare: May Accept Medicare Assignments Practice Location: 23 Spring St, Scarborough, ME 04074 Phone: 207-883-6466 Fax: 207-883-6556 |
 Hbc Marty Layne Associates, Llc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 23 Spring St, Suite D, Scarborough, ME 04074 Phone: 207-883-6466 Fax: 207-883-6556 |
Allison Reitz, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 92 Campus Dr Ste C, Scarborough, ME 04074 Phone: 207-797-5753 |
Marty Layne Audiology Audiologist Medicare: Not Enrolled in Medicare Practice Location: 23 Spring Street, Suite D, Scarborough, ME 04074 Phone: 207-883-6466 Fax: 207-883-6556 |
Dr. Marty Layne, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 23 Spring St, Scarborough, ME 04074 Phone: 207-883-6466 Fax: 207-883-6556 |
Dr. Jaime Roy Onofrio Audiologist Medicare: Accepting Medicare Assignments Practice Location: 92 Campus Dr Fl 3, Scarborough, ME 04074 Phone: 207-797-5753 |
News Archive
Diabetic black men have lower amounts of atherosclerosis than diabetic white men
In a surprising outcome, investigators at Wake Forest University Baptist Medical Center found that diabetic black men have dramatically lower amounts of atherosclerosis, or hardening of the arteries, than diabetic white men.
Study reveals that allergies are a major health issue in Sweden
Asthma, nasal symptoms and eczema is a major public health problem in Sweden, not least among young people. Half of all teenagers are affected in Västra Götaland County in West Sweden.
Combining nanotechnology with immunotherapy to fight deadly metastatic breast cancer
A team of scientists led by a researcher at the Case Western Reserve University School of Medicine is making strides to fight deadly metastatic breast cancer by combining nanotechnology with immunotherapy.
NexMed raises $2.3M through private placement
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology , announced today that it has raised $2.3 million in a private placement of promissory notes from two accredited U.S. investors. The promissory notes, due on or before August 4, 2010, are repayable at NexMed's option in either cash or shares of unregistered common stock at prices ranging from $0.36 to $0.40 per share.
› Verified 7 days ago
Physical Therapists
Occupational Therapists
Speech-Language Pathologists
Chiropractors
Audiologists
Optometrists
Podiatrists